Galway's Crospon secures FDA approval for reflux-testing tool

Galway-based medical device developer Crospon has received approval form the US Food and Drugs Administration (FDA) for its diagnostic test for gastroesophageal reflux disease EndoFLIP.

Galway-based medical device developer Crospon has received approval form the US Food and Drugs Administration (FDA) for its diagnostic test for gastroesophageal reflux disease EndoFLIP.

The company is now free to sell EndoFLIP in the US.

You have reached your article limit. Already a subscriber? Sign in

185 years of the Irish Examiner

185th
Anniversary Offer

Six months of digital access for €18.50

No obligation. Ts&Cs apply.

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited